CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+3.15%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$3.85B
AUM Growth
+$3.85B
(-3.8%)
Cap. Flow
-$240M
Cap. Flow
% of AUM
-6.24%
Top 10 Holdings %
Top 10 Hldgs %
17.74%
Holding
706
New
68
Increased
292
Reduced
227
Closed
52
Top Buys
| 1 |
AET
Aetna Inc
AET
|
$22.9M |
| 2 |
Abbott
ABT
|
$22.2M |
| 3 |
Johnson & Johnson
JNJ
|
$21.7M |
| 4 |
Analog Devices
ADI
|
$19.2M |
| 5 |
Cummins
CMI
|
$17.1M |
Top Sells
| 1 |
Intel
INTC
|
$46M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
$38.4M |
| 3 |
AbbVie
ABBV
|
$37.7M |
| 4 |
NVIDIA
NVDA
|
$24.7M |
| 5 |
Gilead Sciences
GILD
|
$22.7M |
Sector Composition
| 1 | Healthcare | 24.55% |
| 2 | Financials | 13.06% |
| 3 | Technology | 10.26% |
| 4 | Consumer Staples | 10.19% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Amgen
AMGN
$155B
| $89.6M | 2.33% |
588,715
-111,618
| -16% | -$17M |
|
|
2
Johnson & Johnson
JNJ
$427B
| $88.4M | 2.3% |
728,944
+179,216
| +33% | +$21.7M |
|
|
3
Gilead Sciences
GILD
$140B
| $76.3M | 1.98% |
914,184
-272,601
| -23% | -$22.7M |
|
|
4
Alphabet (Google) Class A
GOOGL
$2.57T
| $71.5M | 1.86% |
101,665
-54,639
| -35% | -$38.4M |
|
5
PepsiCo
PEP
$204B
| $69.4M | 1.8% |
654,969
-126,121
| -16% | -$13.4M |
|
6
Procter & Gamble
PG
$368B
| $62.2M | 1.62% |
734,565
-120,132
| -14% | -$10.2M |
|
7
Amazon
AMZN
$2.44T
| $60.5M | 1.57% |
84,480
+858
| +1% | +$614K |
|
8
Exxon Mobil
XOM
$487B
| $59.3M | 1.54% |
632,231
+52,384
| +9% | +$4.91M |
|
9
Apple
AAPL
$3.45T
| $55.9M | 1.45% |
585,159
-23,959
| -4% | -$2.29M |
|
10
Meta Platforms (Facebook)
META
$1.86T
| $49.2M | 1.28% |
430,329
+24,797
| +6% | +$2.83M |
|
11
Pfizer
PFE
$141B
| $47.3M | 1.23% |
1,344,041
+151,761
| +13% | +$5.34M |
|
12
Cisco
CSCO
$274B
| $46.6M | 1.21% |
1,623,437
+476,822
| +42% | +$13.7M |
|
13
Microsoft
MSFT
$3.77T
| $44.6M | 1.16% |
871,604
-102,939
| -11% | -$5.27M |
|
|
CELG
14
DELISTED
Celgene Corp
CELG
| $43.4M | 1.13% |
440,062
-140,577
| -24% | -$13.9M |
|
15
AT&T
T
$209B
| $42.7M | 1.11% |
988,543
-80,099
| -7% | -$3.46M |
|
16
Biogen
BIIB
$19.4B
| $40.1M | 1.04% |
165,861
-15,539
| -9% | -$3.76M |
|
17
Verizon
VZ
$186B
| $39.8M | 1.03% |
712,190
-25,653
| -3% | -$1.43M |
|
18
3M
MMM
$82.8B
| $38.3M | 0.99% |
218,414
-1,674
| -0.8% | -$293K |
|
|
19
Analog Devices
ADI
$124B
| $35.3M | 0.92% |
623,417
+339,513
| +120% | +$19.2M |
|
20
Regeneron Pharmaceuticals
REGN
$61.5B
| $33.2M | 0.86% |
95,104
+24,146
| +34% | +$8.43M |
|
21
JPMorgan Chase
JPM
$829B
| $30.9M | 0.8% |
497,441
+189,240
| +61% | +$11.8M |
|
22
Visa
V
$683B
| $30.3M | 0.79% |
408,823
+63,232
| +18% | +$4.69M |
|
23
Philip Morris
PM
$260B
| $29.8M | 0.77% |
292,527
+6,338
| +2% | +$645K |
|
24
Bristol-Myers Squibb
BMY
$96B
| $29.3M | 0.76% |
398,360
-28,691
| -7% | -$2.11M |
|
25
GE Aerospace
GE
$292B
| $29.3M | 0.76% |
929,453
+349,522
| +60% | +$11M |
|